Biochemical Diagnostic Reagent Comprehensive Study by Type (Chromatography reagents, Molecular Diagnostic Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents), By category (In-Vivo diagnostic, In-Vitro diagnostic), By End User (Hospital, Laboratories, Research institutions, Others) Players and Region - Global Market Outlook to 2028

Biochemical Diagnostic Reagent Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Biochemical Diagnostic Reagent Market Scope
Biochemical reagents are used to perform chemical reactions controlled by biomolecules in living organisms and to study elements and compounds. These products may include peptides, proteins, lipids, carbohydrates, histology products, stains, and others. Diagnostic reagent. Substances used in diagnostic tests to detect disease agents or antibodies by causing an identifiable reaction. Biochemical reagents refer to any chemical that is found in a biological system or that can be used for biological research. Biochemical reagents include molecules like amino acids, vitamins and nucleotides that are essential to life. Rise in chronic diseases is the driver the market toward the growth.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledSiemens (Germany), Hologic, Inc. (United States), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (United States), BD (United States), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (United States), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (United States) and Shimadzu Medical (India) pvt. Ltd. (Japan)
CAGR%


Biochemical Diagnostic Reagent Market is a fragmented market due to the presence of various players. The players are focusing on increasing their manufacturing capacity and are offering competitive prices to gain high market share and establish their position in the market. Further, companies are focusing on developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Siemens (Germany), Hologic, Inc. (United States), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Abbott (United States), BD (United States), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (United States), Koninklijke Philips N.V. (Netherlands), NeuroLogica Corp. (United States) and Shimadzu Medical (India) pvt. Ltd. (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Quest Diagnostics Incorporated (United states) and Sysmex India Pvt. Ltd. (Japan).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Biochemical Diagnostic Reagent market by Type and Region with country level break-up.

On the basis of geography, the market of Biochemical Diagnostic Reagent has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies

In 2021, CYTENA launched C. LIVE Tox, reagents for real-time direct detection of cytotoxicity. C.LIVE Tox Green and Red are sensitive DNA-binding dyes that are nonpermeable to viable cells and nonfluorescent on the outside.


Influencing Trend:
Increasing application of reagents in separation of biomolecules and chemical molecules

Market Growth Drivers:
Rise in chronic diseases

Challenges:
Lack of healthcare infrastructure in developing economies

Restraints:
Expensive material

Opportunities:
More government efforts are being implemented to combat influenza outbreaks. and aging populace expanding

Key Target Audience
Medical Equipment manufacturers, Pharmaceutical companies, Government and private laboratories, Research and Development (R&D) companies, Medical research laboratories, Market research and consulting service providers, Government Agencies, End User Industry and Others

Report Objectives / Segmentation Covered

By Type
  • Chromatography reagents
  • Molecular Diagnostic Reagents
  • Immunoassay Reagents
  • Clinical Chemistry Reagents
  • Flow Cytometry Reagents
By By category
  • In-Vivo diagnostic
  • In-Vitro diagnostic

By By End User
  • Hospital
  • Laboratories
  • Research institutions
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in chronic diseases
    • 3.3. Market Challenges
      • 3.3.1. Lack of healthcare infrastructure in developing economies
    • 3.4. Market Trends
      • 3.4.1. Increasing application of reagents in separation of biomolecules and chemical molecules
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biochemical Diagnostic Reagent, by Type, By category , By End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Biochemical Diagnostic Reagent (Value)
      • 5.2.1. Global Biochemical Diagnostic Reagent by: Type (Value)
        • 5.2.1.1. Chromatography reagents
        • 5.2.1.2. Molecular Diagnostic Reagents
        • 5.2.1.3. Immunoassay Reagents
        • 5.2.1.4. Clinical Chemistry Reagents
        • 5.2.1.5. Flow Cytometry Reagents
      • 5.2.2. Global Biochemical Diagnostic Reagent Region
        • 5.2.2.1. South America
          • 5.2.2.1.1. Brazil
          • 5.2.2.1.2. Argentina
          • 5.2.2.1.3. Rest of South America
        • 5.2.2.2. Asia Pacific
          • 5.2.2.2.1. China
          • 5.2.2.2.2. Japan
          • 5.2.2.2.3. India
          • 5.2.2.2.4. South Korea
          • 5.2.2.2.5. Taiwan
          • 5.2.2.2.6. Australia
          • 5.2.2.2.7. Rest of Asia-Pacific
        • 5.2.2.3. Europe
          • 5.2.2.3.1. Germany
          • 5.2.2.3.2. France
          • 5.2.2.3.3. Italy
          • 5.2.2.3.4. United Kingdom
          • 5.2.2.3.5. Netherlands
          • 5.2.2.3.6. Rest of Europe
        • 5.2.2.4. MEA
          • 5.2.2.4.1. Middle East
          • 5.2.2.4.2. Africa
        • 5.2.2.5. North America
          • 5.2.2.5.1. United States
          • 5.2.2.5.2. Canada
          • 5.2.2.5.3. Mexico
  • 6. Biochemical Diagnostic Reagent: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hologic, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BD (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Koninklijke Philips N.V. (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NeuroLogica Corp. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Shimadzu Medical (India) pvt. Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Biochemical Diagnostic Reagent Sale, by Type, By category , By End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Biochemical Diagnostic Reagent (Value)
      • 7.2.1. Global Biochemical Diagnostic Reagent by: Type (Value)
        • 7.2.1.1. Chromatography reagents
        • 7.2.1.2. Molecular Diagnostic Reagents
        • 7.2.1.3. Immunoassay Reagents
        • 7.2.1.4. Clinical Chemistry Reagents
        • 7.2.1.5. Flow Cytometry Reagents
      • 7.2.2. Global Biochemical Diagnostic Reagent Region
        • 7.2.2.1. South America
          • 7.2.2.1.1. Brazil
          • 7.2.2.1.2. Argentina
          • 7.2.2.1.3. Rest of South America
        • 7.2.2.2. Asia Pacific
          • 7.2.2.2.1. China
          • 7.2.2.2.2. Japan
          • 7.2.2.2.3. India
          • 7.2.2.2.4. South Korea
          • 7.2.2.2.5. Taiwan
          • 7.2.2.2.6. Australia
          • 7.2.2.2.7. Rest of Asia-Pacific
        • 7.2.2.3. Europe
          • 7.2.2.3.1. Germany
          • 7.2.2.3.2. France
          • 7.2.2.3.3. Italy
          • 7.2.2.3.4. United Kingdom
          • 7.2.2.3.5. Netherlands
          • 7.2.2.3.6. Rest of Europe
        • 7.2.2.4. MEA
          • 7.2.2.4.1. Middle East
          • 7.2.2.4.2. Africa
        • 7.2.2.5. North America
          • 7.2.2.5.1. United States
          • 7.2.2.5.2. Canada
          • 7.2.2.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biochemical Diagnostic Reagent: by Type(USD Million)
  • Table 2. Biochemical Diagnostic Reagent Chromatography reagents , by Region USD Million (2017-2022)
  • Table 3. Biochemical Diagnostic Reagent Molecular Diagnostic Reagents , by Region USD Million (2017-2022)
  • Table 4. Biochemical Diagnostic Reagent Immunoassay Reagents , by Region USD Million (2017-2022)
  • Table 5. Biochemical Diagnostic Reagent Clinical Chemistry Reagents , by Region USD Million (2017-2022)
  • Table 6. Biochemical Diagnostic Reagent Flow Cytometry Reagents , by Region USD Million (2017-2022)
  • Table 7. South America Biochemical Diagnostic Reagent, by Country USD Million (2017-2022)
  • Table 8. South America Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 9. South America Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 10. South America Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 11. Brazil Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 12. Brazil Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 13. Brazil Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 14. Argentina Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 15. Argentina Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 16. Argentina Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 17. Rest of South America Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 18. Rest of South America Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 19. Rest of South America Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 20. Asia Pacific Biochemical Diagnostic Reagent, by Country USD Million (2017-2022)
  • Table 21. Asia Pacific Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 22. Asia Pacific Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 23. Asia Pacific Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 24. China Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 25. China Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 26. China Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 27. Japan Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 28. Japan Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 29. Japan Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 30. India Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 31. India Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 32. India Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 33. South Korea Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 34. South Korea Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 35. South Korea Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 36. Taiwan Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 37. Taiwan Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 38. Taiwan Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 39. Australia Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 40. Australia Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 41. Australia Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 42. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 43. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 44. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 45. Europe Biochemical Diagnostic Reagent, by Country USD Million (2017-2022)
  • Table 46. Europe Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 47. Europe Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 48. Europe Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 49. Germany Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 50. Germany Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 51. Germany Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 52. France Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 53. France Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 54. France Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 55. Italy Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 56. Italy Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 57. Italy Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 58. United Kingdom Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 59. United Kingdom Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 60. United Kingdom Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 61. Netherlands Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 62. Netherlands Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 63. Netherlands Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 64. Rest of Europe Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 65. Rest of Europe Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 66. Rest of Europe Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 67. MEA Biochemical Diagnostic Reagent, by Country USD Million (2017-2022)
  • Table 68. MEA Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 69. MEA Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 70. MEA Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 71. Middle East Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 72. Middle East Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 73. Middle East Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 74. Africa Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 75. Africa Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 76. Africa Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 77. North America Biochemical Diagnostic Reagent, by Country USD Million (2017-2022)
  • Table 78. North America Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 79. North America Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 80. North America Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 81. United States Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 82. United States Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 83. United States Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 84. Canada Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 85. Canada Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 86. Canada Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 87. Mexico Biochemical Diagnostic Reagent, by Type USD Million (2017-2022)
  • Table 88. Mexico Biochemical Diagnostic Reagent, by By category USD Million (2017-2022)
  • Table 89. Mexico Biochemical Diagnostic Reagent, by By End User USD Million (2017-2022)
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Company Basic Information, Sales Area and Its Competitors
  • Table 92. Company Basic Information, Sales Area and Its Competitors
  • Table 93. Company Basic Information, Sales Area and Its Competitors
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Biochemical Diagnostic Reagent: by Type(USD Million)
  • Table 101. Biochemical Diagnostic Reagent Chromatography reagents , by Region USD Million (2023-2028)
  • Table 102. Biochemical Diagnostic Reagent Molecular Diagnostic Reagents , by Region USD Million (2023-2028)
  • Table 103. Biochemical Diagnostic Reagent Immunoassay Reagents , by Region USD Million (2023-2028)
  • Table 104. Biochemical Diagnostic Reagent Clinical Chemistry Reagents , by Region USD Million (2023-2028)
  • Table 105. Biochemical Diagnostic Reagent Flow Cytometry Reagents , by Region USD Million (2023-2028)
  • Table 106. South America Biochemical Diagnostic Reagent, by Country USD Million (2023-2028)
  • Table 107. South America Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 108. South America Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 109. South America Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 110. Brazil Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 111. Brazil Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 112. Brazil Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 113. Argentina Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 114. Argentina Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 115. Argentina Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 116. Rest of South America Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 117. Rest of South America Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 118. Rest of South America Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 119. Asia Pacific Biochemical Diagnostic Reagent, by Country USD Million (2023-2028)
  • Table 120. Asia Pacific Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 121. Asia Pacific Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 122. Asia Pacific Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 123. China Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 124. China Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 125. China Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 126. Japan Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 127. Japan Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 128. Japan Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 129. India Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 130. India Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 131. India Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 132. South Korea Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 133. South Korea Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 134. South Korea Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 135. Taiwan Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 136. Taiwan Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 137. Taiwan Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 138. Australia Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 139. Australia Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 140. Australia Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 141. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 142. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 143. Rest of Asia-Pacific Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 144. Europe Biochemical Diagnostic Reagent, by Country USD Million (2023-2028)
  • Table 145. Europe Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 146. Europe Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 147. Europe Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 148. Germany Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 149. Germany Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 150. Germany Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 151. France Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 152. France Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 153. France Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 154. Italy Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 155. Italy Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 156. Italy Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 157. United Kingdom Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 158. United Kingdom Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 159. United Kingdom Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 160. Netherlands Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 161. Netherlands Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 162. Netherlands Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 163. Rest of Europe Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 164. Rest of Europe Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 165. Rest of Europe Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 166. MEA Biochemical Diagnostic Reagent, by Country USD Million (2023-2028)
  • Table 167. MEA Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 168. MEA Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 169. MEA Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 170. Middle East Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 171. Middle East Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 172. Middle East Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 173. Africa Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 174. Africa Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 175. Africa Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 176. North America Biochemical Diagnostic Reagent, by Country USD Million (2023-2028)
  • Table 177. North America Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 178. North America Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 179. North America Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 180. United States Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 181. United States Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 182. United States Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 183. Canada Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 184. Canada Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 185. Canada Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 186. Mexico Biochemical Diagnostic Reagent, by Type USD Million (2023-2028)
  • Table 187. Mexico Biochemical Diagnostic Reagent, by By category USD Million (2023-2028)
  • Table 188. Mexico Biochemical Diagnostic Reagent, by By End User USD Million (2023-2028)
  • Table 189. Research Programs/Design for This Report
  • Table 190. Key Data Information from Secondary Sources
  • Table 191. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biochemical Diagnostic Reagent: by Type USD Million (2017-2022)
  • Figure 5. South America Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 6. Asia Pacific Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 7. Europe Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 8. MEA Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 9. North America Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 10. Global Biochemical Diagnostic Reagent share by Players 2022 (%)
  • Figure 11. Global Biochemical Diagnostic Reagent share by Players (Top 3) 2022(%)
  • Figure 12. Global Biochemical Diagnostic Reagent share by Players (Top 5) 2022(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 15. Siemens (Germany) Revenue: by Geography 2022
  • Figure 16. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Hologic, Inc. (United States) Revenue: by Geography 2022
  • Figure 18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) Revenue: by Geography 2022
  • Figure 20. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott (United States) Revenue: by Geography 2022
  • Figure 22. BD (United States) Revenue, Net Income and Gross profit
  • Figure 23. BD (United States) Revenue: by Geography 2022
  • Figure 24. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 25. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2022
  • Figure 26. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2022
  • Figure 28. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 29. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2022
  • Figure 30. NeuroLogica Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 31. NeuroLogica Corp. (United States) Revenue: by Geography 2022
  • Figure 32. Shimadzu Medical (India) pvt. Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 33. Shimadzu Medical (India) pvt. Ltd. (Japan) Revenue: by Geography 2022
  • Figure 34. Global Biochemical Diagnostic Reagent: by Type USD Million (2023-2028)
  • Figure 35. South America Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 36. Asia Pacific Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 37. Europe Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 38. MEA Biochemical Diagnostic Reagent Share (%), by Country
  • Figure 39. North America Biochemical Diagnostic Reagent Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Siemens (Germany)
  • Hologic, Inc. (United States)
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Abbott (United States)
  • BD (United States)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Thermo Fisher Scientific Inc. (United States)
  • Koninklijke Philips N.V. (Netherlands)
  • NeuroLogica Corp. (United States)
  • Shimadzu Medical (India) pvt. Ltd. (Japan)
Additional players considered in the study are as follows:
Quest Diagnostics Incorporated (United states) , Sysmex India Pvt. Ltd. (Japan)
Select User Access Type

Key Highlights of Report


Apr 2023 217 Pages 92 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Biochemical Diagnostic Reagent Market are by type [Chromatography reagents, Molecular Diagnostic Reagents, Immunoassay Reagents, Clinical Chemistry Reagents and Flow Cytometry Reagents], by end use application [].
The Biochemical Diagnostic Reagent Market is gaining popularity and expected to see strong valuation by 2028.

Know More About Global Biochemical Diagnostic Reagent Market Report?